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Abstract Stem cells from the adult hair follicle
bulge can differentiate into neurons and glia, which is
advantageous for the development of an autologous
cell-based therapy for neurological diseases. Conse-
quently, bulge stem cells from plucked hair may
increase opportunities for personalized neuroregener-
ative therapy. Hairs were plucked from the scalps of
healthy donors, and the bulges were cultured without
prior tissue treatment. Shortly after outgrowth from
the bulge, cellular protein expression was established
immunohistochemically. The doubling time was cal-
culated upon expansion, and the viability of expanded,
cryopreserved cells was assessed after shear stress.
The neuroglial differentiation potential was assessed
from cryopreserved cells. Shortly after outgrowth, the
cells were immunopositive for nestin, SLUG, AP-2a
and SOX9, and negative for SOX10. Each bulge
yielded approximately 1 9 104 cells after three pas-
sages. Doubling time was 3.3 (±1.5) days. Cellular
viability did not differ significantly from control cells
after shear stress. The cells expressed class III b-
tubulin (TUBB3) and synapsin-1 after 3 weeks of
neuronal differentiation. Glial differentiation yielded
KROX20- and MPZ-immunopositive cells after
2 weeks. We demonstrated that human hair follicle
bulge-derived stem cells can be cultivated easily,
expanded efficiently and kept frozen until needed.
After cryopreservation, the cells were viable and
displayed both neuronal and glial differentiation
potential.
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Introduction
During the last decade, the interest in autologous stem
cells has increased considerably, especially regarding
the development of individualized therapies (Pra-
songchean and Ferretti 2012). However, the procure-
ment of autologous somatic stem cells for human
therapeutic purposes is still limited. In addition,
somatic stem cell potency is restricted, and multipo-
tent rather than pluripotent (Prasongchean and Ferretti
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2012). Reprogramming somatic cells into induced
pluripotent stem cells by the forced expression of
certain genes is being explored but is controversial,
since they are often tumorigenic and may initialize a T
cell-dependent immune response in syngeneic recip-
ients (Zhang et al. 2012; Zhao et al. 2011; Fu 2013).
For these reasons, the use of other types of
autologous somatic stem cells is currently under
investigation, such as bone marrow stem cells in a
curative treatment for ischemic heart patients and
cerebral infarction (Tian et al. 2014; Kasahara et al.
2013), already showing some promising results. One
of the risks with this approach is that stem cells may
follow their innate biological inclination irrespective
of the tissue or organ into which they have been
grafted. This was demonstrated by the finding that
autologous bone marrow stem cells can produce
extracellular matrix after engraftment into the brain
(Grigoriadis et al. 2011; Snyder 2011). An alternative
strategy could involve the use of neural crest-derived
stem cells (NCSCs). They are appropriate for autol-
ogous cell-based therapy in many diseases, as they can
be derived from adult tissue and can give rise to many
cell types from ectodermal and mesodermal lineages.
NCSCs from adult tissue (aNCSCs) are nononcogenic
and possess a broad regenerative potential (Achilleos
and Trainor 2012). In culture, aNCSCs retain their
neural crest potential to differentiate into a variety of
cells including adipocytes, chondrocytes, neurons,
glia, osteocytes, and muscle cells (Achilleos and
Trainor 2012). Minimally invasive, easily accessible
sources for NCSCs are the olfactory sheath, palate,
dental pulp and the hair follicle bulge (Achilleos and
Trainor 2012). We consider the hair follicle to be the
most easily accessible option (Huisman and Rivolta
2012). It has been reported that hair follicle bulge-
derived NCSCs (HFBSCs) from human adults still
possess neural crest characteristics such as multipo-
tency (Mistriotis and Andreadis 2013; Sieber-Blum
et al. 2004; Yu et al. 2010; Amoh et al. 2009a, b). This
multipotency is of particular use in the area of
neuroregeneration, given that hair follicle stem cells
can promote the functional recovery of injured
peripheral and central nerves (Amoh et al. 2008,
2009a, b; Hu et al. 2010). Hence, autologous HFBSCs
are potentially suitable for therapeutic application in a
broad range of neurological disorders such as ALS,
Alzheimer’s disease and stroke. They also may be
used in cell-based therapies for sensory neurological
diseases such as those for ocular or inner ear regen-
eration (Liu et al. 2014; Huisman and Rivolta 2012). If
HFBSCs could be harvested from plucked hairs, their
practical utilization for autologous stem cell therapy
would increase immensely. We therefore aimed to
establish that:
1. Follicular stem cells, migrated out of the bulge
from plucked hair follicles, are nestin-positive and
possess a neural crest stem cell immunopheno-
type. Moreover, due to the cytotoxic nature of
proteases, we intend to minimize the enzymatic
treatments of tissue and cells (Aoshiba et al.
2001).
2. HFBSCs can be used for transplantation purposes,
because they can be expanded easily and remain
viable after cryopreservation and needle shear
stress.
3. These stem cells are suitable as a source for future
neural regenerative medicine in the patient, i.e.
they can be stored frozen while keeping their
neural and glial differentiation capacity.
Materials and methods
Specimen
Plucked hairs from healthy donors were obtained from
the occipital area of the scalp. The hairs were removed
with depilation forceps. All human material was
handled according to the Dutch Medical Treatment
Agreement Act (Dutch Civil Code, Book 7, Sec-
tion 7.7.5, article 7:467; http://www.dutchcivillaw.
com/legislation/dcctitle7777.htm). Intact hair follicles
(HFs) in the anagen phase were selected under a dis-
section microscope, and placed in DMEM/Ham’s
F-12 1:1 (Biochrom AG, Berlin, Germany) containing
1 % GlutaMAX (100x; Life Technologies, Carlsbad,
CA, USA) and 1 % Antibiotic Antimycotic Solution
(100x; Sigma-Aldrich, St. Louis, MO, USA) (Fig. 1a).
The HFs were processed the next morning.
Isolation and cultivation of HFBSCs
Isolation of HF stem cells was according to Sieber-
Blum et al. (2004) with minor changes. Briefly,
connective tissue (if present) was removed from the
HF and the bulge-containing area was dissected out
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just below the sebaceous gland and well above the
bulb (Fig. 1a). Then, a longitudinal section along the
tissue of the bulge was made, to cause the tissue to
unfold. During these procedures, care has to be taken
to avoid dehydration of the HF. Before the start of the
culture, tissue culture 12-well plates (TPP; Trasadin-
gen, Switzerland) were coated with poly-D-lysine
(PDL; Sigma-Aldrich) diluted in sterile demi water
(1:10) at 37 C and 5 % CO2 for 1 h. Then the PDL
solution was removed and the wells air-dried under
sterile conditions. Prior to usage, the PDL matrix was
rehydrated with basic growth medium (BGM, 37 C,
30 min). BGM consisted of DMEM/Ham’s F-12 1:1,
containing 1 % GlutaMAX, 1 % Antibiotic Antimy-
cotic Solution, supplemented with 10 % fetal bovine
serum Gold (FBS; Life Technologies), 2 % B-27
Supplement without vitamin A (50x; Life Technolo-
gies), 1 % N-2 MAX Media Supplement (100x; R&D
Systems, Minneapolis, MN, USA), recombinant
human Fibroblast Growth Factor-basic (rhFGF-basic;
20 ng/ml; R&D Systems), and recombinant human
Epidermal Growth Factor (rhEGF; 20 ng/ml; R&D
Systems). After rehydration, the BGM was poured out
of the wells, and one HF-bulge was placed in each
well. The HFs were carefully pressed on the bottom of
the well using a forceps. Subsequently, three incuba-
tion periods in a small drop of medium allowed the HF
to attach to the matrix. Incubation was done at 37 C
and 5 % CO2 for 75 min. If necessary, some medium
was added. Finally, 500 ll of freshly prepared BGM
was added cautiously. The primary culture was
established by the outgrowth of HF stem cells from
the bulge, usually at 8–10 days after the start of the
culturing. After 1 week of culturing, a complete
medium change was performed, followed by replace-
ment of half of the medium every other day. Three to
four days after the start of outgrowth, the HF bulge was
removed and some of the cultures were fixed with 1 %
formaldehyde in PBS (FA) for immunohistochemical
analysis of neural crest markers.
Expansion and cryopreservation
After removal of the bulge, cells were grown to
60–70 % confluence and enzymatically detached
using pre-warmed 0.05 % trypsin–EDTA (Life Tech-
nologies) at 37 C for precisely 2 min. Trypsinization
was stopped by the addition of DMEM/HAM’s F-12
1:1 supplemented with 10 % FBS. The cells were
centrifuged at 2809g for 10 min, and the cell pellet
was suspended in 1 ml BGM. After cell counting
(Logos Biosystems, Anyang-City, Korea), the cells
were seeded at expansion density (2.5 9 103 cells per
cm2) in a PDL-coated dish and allowed to expand until
60–70 % confluence. In general, cells were passaged
three to four times. Each period of time prior to
passaging was about 1 week. Doubling times were
calculated at passages 2 and 3, using the site: Roth V.
2006 Doubling Time Computing, Available from:
http://www.doubling-time.com/compute.php (Kim et al.
2011).
In addition, a portion of the cells was frozen at
-80 C at a concentration of 1 9 106 cells/ml in 90 %
FBS with 10 % dimethyl sulfoxide (Sigma-Aldrich).
After storage and thawing, the cells were suspended in
5 ml BGM, centrifuged, collected, suspended in
BGM, carefully triturated, seeded at expansion den-
sity, and cultured at 37 C and 5 % CO2.
Fig. 1 a Hair follicle with an intact inner and outer root sheath.
Only the upper half of the follicle was used (between lines; scale
bar 500 lm). b HF and cells with spindle-like morphology, at
day 2 of outgrowth. The outer root sheath is curled (scale bar
200 lm). c HF and tightly clustered cells with an epithelial
appearance (sheets of flattened polyhedral cells; scale bar
200 lm)
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Simulation of the transplantation procedure:
ejection of cells
After cryopreservation, cells were cultured at 37 C
and 5 % CO2. After 1 week cells were enzymatically
detached and centrifuged at 2809g for 10 min. They
were suspended at a density of*4.0 9 106 cells/ml in
BGM medium and carefully triturated. Subsequently,
10 ll of the cell suspension was loaded into a 100 ll
syringe with a 30 gauge needle and injected into a 1 ml
Eppendorf tube using a programmable syringe pump
(Prosense, Oosterhout, The Netherlands); settings:
diameter 4.699 mm—rate 0.5 ml/min. Both cultured
and cryopreserved cells were subjected to shear stress.
Viability was assessed using the trypan blue test.
Trypan blue staining is based on the principle that live
cells possess intact cell membranes that exclude the
dye, whereas dead cells do not (Strober 2001). A 1:1
dilution of cell suspension and 0.4 % trypan blue was
incubated for 2 min at room temperature. Next, the
stained cells were counted using a Neubauer haemo-
cytometer chamber and calculated using the following
formula: vital cell rate (%) = number of vital cells/
(number of vital cells ? number of dead cells) 9
100 %. Cells that had been cultured but not injected
served as controls.
Statistical analysis
The paired, two-tailed Student’s t test was used to
estimate the difference between the control and
injected cells. The unpaired, two-tailed Student’s
t test was used to estimate the difference between
control cells and both cryopreserved and injected
cryopreserved cells.
Neural differentiation of HFBSCs
Following outgrowth, expansion, and cryopreserva-
tion of HFBSCs, 2.5 9 105 cells in 500 ll of BGM
were seeded per well of a 12-well plate. The cells were
seeded via the side into PDL-coated wells containing
PDL-coated cover glasses (Thermo Scientific, Wal-
tham, MA, USA). It was essential in all the described
procedures to prevent the cover glass sticking to the
bottom of the well. Prior to PDL coating, the cover
glasses were etched in 85 % phosphoric acid (Merck
Millipore, Darmstadt, Germany) for 12 h (Beaudoin
III et al. 2012). Subsequently, acid-treated cover
glasses were rinsed extensively in ultrapure water and
subjected to a graded series of 70, 90, and 96 %
ethanol. Cover glasses were stored in 96 % ethanol.
The 12-well plates and etched cover glasses were
coated separately with PDL as described previously.
After seeding, the cells were cultured at 37 C and
5 % CO2, while their settlement underneath the cover
glass was observed daily. When an appropriate density
was achieved, i.e., 5 to 10 cells in one field of view
(FOV, 109 magnification, an area of *3.5 mm2),
differentiation was induced by removal of 250 ll
medium and replacement with 300 ll cAMP-contain-
ing induction medium (IM) (Jarmalavicˇiu¯t _e et al.
2013). IM consisted of DMEM/Ham’s F-12 1:1
supplemented with 1.5 mM cAMP (Sigma-Aldrich),
1 % glutamax (Life Technologies), 10 ng/ml NGF,
10 ng/ml GDNF, 10 ng/ml BDNF (all from R&D
Systems) and 2 % B27 ? VitA (Life Technologies).
If the appropriate density was not achieved, half of the
medium was replaced with fresh BGM every other
day. After IM was added, the cultures were allowed to
differentiate for at least 60 h without disturbance due
to opening of the incubator or observation of the cells.
Subsequently, 250 ll medium was removed and again
substituted with 300 ll IM. Thereafter, the medium
was replenished with IM every other day. Cultures
were observed for morphological changes on a daily
basis. If no neuronal morphologies appeared after
7 days of differentiation, the culture underwent
another period without disturbance in IM, and the
above-mentioned differentiation procedure was fol-
lowed again. After differentiation for 7–14 days, the
cover glass was carefully removed, because cells were
not only attached to the bottom of the well but
sometimes also to the underside of the cover glass. The
cells on the bottom of the well were fixed in 1 % FA
for 15 min and processed for immunohistochemistry.
Fixed cells were stored at 4 C for a maximum period
of 2 weeks.
Glial differentiation of HFBSCs
After expansion, a volume of 500 ll of BGM
(without FBS) containing 1 9 105 cells was pipetted
into each well of a 12-well plate. The cells were
seeded via the side into uncoated wells which
contained PDL-coated cover glasses. During culture,
the cover glass should not stick to the bottom of the
well. On the next day, half of the medium was
1852 Cytotechnology (2016) 68:1849–1858
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replaced with serum-free BGM (Pacey et al. 2006).
Cells were observed every other day to follow
settlement and changes in morphology. The medium
was exchanged with serum-free medium every other
day until an average density of 10–20 cells per FOV
underneath the cover glass was reached. Then half of
the medium was replaced by IM. The cells under-
neath the cover glass usually adopt glial-like mor-
phologies after 3–4 days of induction. After
induction, the medium was exchanged once a week
with IM. Cultures were maintained until networks of
cells were observed. Because the networks were
attached to the underside of the cover glass, the cover
glasses were removed and placed upside down in
another well of a 12-well dish. The cells were fixed
in 1 % FA for 15 min.
Immunohistochemistry
Prior to immunohistochemistry, the cells were washed
with 0.05 % Tween-20 in PBS for 5 min and perme-
abilized in 0.1 % Triton X-100 in PBS for 10 min.
Cells were treated with blocking solution consisting of
5 % non-immune serum in 0.05 % Tween-20 in PBS
for 30 min. Afterwards, the cells were incubated with
the primary antibodies in blocking solution at 4 C
overnight (Petersen and Pedersen 2013). The primary
antibodies used were: anti-Nestin (1:500, Biosensis,
Thebarton, South Australia), anti-SLUG (1:125,
Abcam (Cambridge, U.K.) ab 27568), anti-AP-2a
(1:100, Santa Cruz Biotechnology (Santa Cruz, CA,
USA) sc-53164), anti-SOX9 (1:500, Millipore (Bil-
lerica, MA, USA) AB5535), anti-SOX10 (1:200,
Santa Cruz sc-17342), anti-b-III-tubulin (1:200,
Abcam ab18207), anti-synapsin-1 (1:200, Abcam
ab8), anti-myelin protein zero (MPZ; 1:200, Neu-
romics (Minneapolis, MN, USA) Ch23009), and anti-
Krox20 (1:100, Covance, New York, NY, USA). The
secondary fluorochrome-conjugated antibodies were
diluted 1:500 in blocking buffer, and the cells were
incubated at room temperature for 1 h. The secondary
antibodies were conjugated with either Alexa Fluor
488 or Alexa Fluor 555 (Life Technologies). Nuclear
counterstaining was performed with 1:1000 DAPI
(Life Technologies, D3571) in PBS. The cells were
covered with Vectashield (Vector Laboratories, Bur-
lingame, CA, USA). Omission of the primary antibody
served as a control for false cross-reactivity of the
secondary antibody. Pertinent positive cell or tissue
controls were used: RT4-D6P2T, a rat Schwann cell
line (ATCC, Manassas, VA, USA) for anti-nestin,
-SOX9, -Krox20, and -MPZ, the Melan-Ink4a cell line
(Wellcome Trust Functional Genomics Cell Bank,
London, UK) for anti-SOX10 and -b-III-tubulin
(Locher et al. 2013), the SKBR3-breast cancer cell
line for anti-SLUG and Ap-2a, and mouse brain for
anti-synapsin-1.
Fluorescence imaging was performed using fluo-
rescence microscopy (Olympus IX70) in combination
with the LAS AF microscope software (Version 1.9.0
build 1633, Leica Microsystems). The data were
corrected for background staining and normalized
using the quantification method of the software. Only
those immunostainings showing a peak maximum at
emission of at least two times higher than the
background were considered to be significantly pos-
itive. Pictures were processed using Adobe Photoshop
CS6 Extended (Version: 13.0 x64, Adobe Systems
Incorporated, San Jose, CA, USA).
Results
Isolation and cultivation of HFBSCs
In our experience, more than 60 % of the bulges
remained attached and produced cellular outgrowth
(Table 1). However, outgrowth did not always yield
the desired phenotype of HFBSCs with spindle-like
morphology (Fig. 1b); tightly clustered cells with an
epithelial appearance were also seen (sheets of
flattened polyhedral cells, Fig. 1c). Both cell pheno-
types emigrated from bulge explants at 8–10 days of
culture. Based on morphology and immunohistochem-
istry (results not shown), the flattened cells were
identified as keratinocytes. Therefore, cultures con-
taining those cells were discarded (Table 1).
In vitro NCSC-characteristic protein expression
profile
The majority of HFBSCs express the neural crest cell
markers SOX9, SLUG, and AP-2a as determined by
indirect immunohistochemistry (Meulemans and
Bronner-Fraser 2004). SOX10 expression was below
the level of detection. The neural progenitor cell
marker nestin was present in all cells (Fig. 2a–e).
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Expansion and cryopreservation
The selected primary (P0) cultures reached 60–70 %
confluence after 15–19 days. The P1 cultures reached
80 % confluence after 1 week and those from P2,
1 week later. The total yield of cells per HF was
approximately 1 9 104. The mean doubling time,
calculated from the P2 and P3 cultures, was 3.3 (±1.5)
days (Table 2).
Simulation of the transplantation procedure:
ejection of cells
Shear stress caused by injection through a syringe
needle did not change the viability of the cells
significantly, whether the cells were freshly cultured
or frozen (p = 0.2401 and p = 0.6306, respectively).
However, a small but significant difference in viability
was found between cells which were only cultured and
those which were cryopreserved (p = 0.009). Never-
theless, after cryopreservation, 82.2 % ± 2.33 % of
the cells were still viable. These results show that
HFBSCs can be expanded and kept frozen until
needed.
Neural differentiation
For neural differentiation, we used the principle of the
‘sandwich method’. The rationale for this method is,
that neuronal survival is improved if the cells are
grown on a substrate-coated surface and covered by a
cover glass (Brewer and Cotman 1989). In general, a
density of about 8 cells per FOV (*3.5 mm2)
underneath the cover glass gave the highest number
Fig. 2 HFBSCs at day 2 of outgrowth. The NCSCmarkers nestin (red), SLUG (red), AP-2a (red) and SOX9 (red) are positive. SOX10
(red) is negative. Nuclei are stained with DAPI (blue; scale bar 100 lm)
Table 1 Outgrowth, adhesion and morphology of cells from the HF bulge explant
Cultures HFs planted
(n)
Cultures with outgrowth
(%)
Cultures with polyhedral
cell outgrowth (%)
Cultures with spindle-like cell
outgrowth (%)
905E1P0 12 58 33 57
906E1P0 12 58 57 43
916E1P0 12 67 37 63
932E1P0 12 67 100 0
934E1P0 30 67 75 25
Average – 63 Discarded 34
Table 2 Doubling times of
HFBSCs after passaging
Cultures Cells at start of culture (n) Cells at end of culture (n) Doubling time (days)
905P1 to P2 199,000 1,872,000 2.8
916P1 to P2 328,000 2,128,000 5.6
934P1 to P2 60,000 1,000,000 2.7
1011P2 to P3 350,000 3,800,000 2.9
1012P1 to P3 350,000 4,400,000 2.7
Avg ± SD 3.3 ± 1.5
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of surviving neuron-like cells during neuronal induc-
tion. A considerable number of cells on top of the
cover glass could not endure neuronal induction and
died, resulting in cellular debris. Too much of this
debris appeared to be destructive to neurons, because
it covered the developing neuron-like cells and their
projections, vacuoles were formed and the neurons
subsequently deteriorated. Under the condition that
cells were not covered by cellular debris, different
neuron-like cells with elongated, branched projections
developed over time. These projections could grow to
a length ranging between 100 and 500 lm (Fig. 3a).
Neuron-like cells were found mainly on the bottom of
the well.
Glial differentiation
After seeding many cells attached within a few
minutes to the PDL matrix, but a considerable number
of HFBSCs remained motile. A considerable number
of these cells migrated underneath the cover glass,
sometimes in globular cell aggregates (Pacey et al.
2006). These cells were mainly bipolar, with a distinct
bulbous soma and small projections. After 2 or 3 days,
most of these cells showed premature glial-like
morphologies. A few days later, their soma became
spherical and the first projections appeared, all very
different in length. These glia-like cells quickly
formed spacious, structured networks. With further
culturing, the cells and networks did not alter
noticeably.
Immunohistochemistry
In general, many cells were b-III-tubulin-positive
early during neural induction, and synapsin-1-positiv-
ity was detectable a few days later (Fig. 3b–d). Glial
induction yielded cells which were b-III-tubulin-
negative, but positive for MPZ and Krox20
(Fig. 3b–d).
Fig. 3 a Representative HFBSCs 14 days after neuronal
induction. Cells at the bottom of the well stained positive for
bIII-Tubulin (green) as well as synapsin-1 (red). The cell
nucleus is stained with DAPI (blue). Merged image reveals
overlay of bIII-Tubulin (green) as well as synapsin-1 (red)
localization. The phase contrast image shows differences in long
dendritic projections and thicker axon (scale bar 50 lm).
b HFBSCs 15 days after glial induction. Glial cells were at the
underside of the cover glass, therefore cells on the top of the
glass are also faintly visible, but out of focus. Cells stained
positive for the glial markers Krox20 (green) and MPZ (red).
Nuclei are stained with DAPI (blue). Cells with a yellow color in
the merged image co-express MPZ (red) and Krox20 (green).
The phase contrast image depicts spindle-shaped morphologies
of the glial cells (scale bar 100 lm). c Migration of glial cells
underneath the cover glass
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Discussion
We isolated, expanded and cryopreserved nestin-
positive stem cells, derived from the bulge area from
plucked human hairs.We showed that these stem cells,
which are also positive for the neural crest markers
SOX9, SLUG and AP-2a, are suitable for transplan-
tation purposes because they easily survive cryop-
reservation and needle shear stress, while conserving
their neuronal differentiation capacities.
The technique used to harvest the HF is virtually
painless and allows the collection of hundreds of HF
per patient. The culture technique to expand the cells is
simple and straightforward and usually yields 1 9 104
cells per HF. Only three to four passages are required
for this high yield, so cellular senescence is not an
issue. Moreover, cellular damage by frequent protease
treatments is restricted to a minimum. We do not
consider the series of conditions mentioned in this
report as imperative protocols, prerequisite to stimu-
lating these cells towards differentiation into neurons
and glia cells. There are some critical points in the
procedures, however, such as the selection of intact
hair follicles, rejection of cultures with undesired cell
outgrowth, and the sandwich differentiation culture
method. Rigorous rejection of cultures based on
critical observations and knowledge of contaminating
cell types allowed us to perform a ‘‘selection at the
gate’’ of the desired cell type. Obviously, the group of
cells which are most prominently present in the hair
follicle are keratinocytes. These cultures were imme-
diately discarded. Other cells present in the hair
follicle are fibroblasts, which possess in the migrating
phase—like many other cells—a spindle-like mor-
phology. However, cultures containing fibroblasts will
soon be overgrown by this contaminating cell type, for
the doubling time of human dermal fibroblasts is in
general 24 h, while the hair follicle bulge stem cells
have a doubling time of an average of 3.3 days (see
also ‘‘Results’’, section Expansion and cryopreserva-
tion). Fibroblasts will thus overgrow the other cells
and form arrays of cells oriented in a curvilinear
pattern. These cultures were also discarded. Other
cells, which have been reported to be present in the
hair follicle are melanocytes, cells from the peripheral
nerve ends and some muscle cells (Locher et al. 2013).
Melanocytes, which in the hair follicle have a similar
morphology as the bulge cells (bipolar), do not grow
under the culture conditions reported here: they need
medium with a relatively low pH, generated by 10 %
CO2. We did not consider Schwann cells from the
peripheral nerve endings as contaminating, for they
are also neural crest-derived. Muscle cells are some-
times present in mouse vibrissae cultures, but we have
never demonstrated them in human hair follicle
cultures (using aSMA staining).
Using the sandwich differentiation method, it was
possible to vary the culture circumstances in such a
way that a different neural cell phenotype was
achieved. It is known that a combination of serum
deprivation, cell density and substrate can direct
neural stem cells to develop towards a neuronal or
glial phenotype (Hung and Young 2006). In the
neuronal differentiation protocol, the surface of the
cover glass was soon covered with many cells, due to
the relatively high seeding density and proliferative
stimulus of FBS. This apparently prevented the
attachment of many cells. Thus, different cell types
remained floating and finally found a habitat under-
neath the cover glass. Some of these cells showed a
fibroblast-like morphology, while others were neuron-
like cells with a small, shining soma and two or more
thin projections. In time, the fibroblast-like cells
disappeared; they apparently did not survive the
differentiation medium. However, there was obvi-
ously contact between the small neuron-like cells and
the fibroblasts, suggesting paracrine interactions
which may stimulate neural differentiation (Moore
et al. 2012). We assume that, because of the decrease
in cell density, neuron-like cells develop long and
complex branches in order to seek contact with other
cells. It is conceivable that the micro-environment
underneath the cover glass, such as a low oxygen
pressure and the build-up of autocrine factors, might
facilitate neuroglial differentiation and survival of
HFBSCs (Brewer and Cotman 1989). Interestingly, in
both protocols, cells with a shining soma and thin
projections preferred migrating underneath the cover
glass while other cells apparently preferred to settle on
top. This cell type-specific affinity to seek a place in
the narrow space between the cover glass and the
bottom of the well, or on top of the cover glass, also
occurred when HFBSCs were seeded underneath the
cover glass (results not shown).
We are convinced that the repertoire of nestin-
positive stem cells from the human HF bulge will be of
benefit for many different autologous cell-based
therapies. Still, there seems to be a difference of
1856 Cytotechnology (2016) 68:1849–1858
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opinion about the precise localization of these cells.
Clewes et al. (2011) described nestin-positive cells
migrating from the HF bulge in culture, whereas
Amoh et al. (2009a, b) found nestin-positive cells
immediately below the sebaceous glands just above
the bulge area, i.e., in the isthmus region. In our
experience, it is nearly impossible to distinguish the
bulge area from the isthmus region in human HFs
(Fig. 1a). We therefore assume that the nestin-positive
cells in our cultures and those described by Clewes
et al. (2011) do not differ from those described by
Amoh et al. (2009a, b), as was also previously
suggested by Djian-Zaouche et al. (2012). Remarkable
positive results of neural regeneration and functional
improvement have been obtained in animal models of
brain, spinal cord, and nerve injury therapy using stem
cells derived from hair follicles (Amoh et al. 2008,
2009a, b; Hu et al. 2010), giving hope for patients
suffering from neurodegenerative diseases. Another
point of interest, however, is the predisposition of
these HFBSCs to repair cranial bone, nerves and tissue
of the head, e.g. in patients with severely burnt faces.
These patients often have enough remaining hair to
perform hair transplantations and to harvest stem cells,
which may open possibilities for complete autologous
facial repair. This holds true for autologous stem cell
therapy in general, as experience with the culturing of
stem cells in autologous serum is increasing (Duggal
and Brinchmann 2011).
Conclusion
We have demonstrated that stem cells from HFs,
plucked from human scalps, display a NCSC immune
profile and can be cultivated, expanded, and kept
frozen until needed. We also showed that differenti-
ation of these stem cells into neurons and glial cells is
feasible. The technique used to harvest the HFs is
almost painless and allows the collection of hundreds
of HFs per patient, which is highly advantageous,
making these cells very attractive for autologous
transplantation and treatment models for a variety of
disorders.
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